EUVIMEDEUVIMED entdecken
Open Access

Evaluating HSP90AA1 as a predictive biomarker for prognosis in lung adenocarcinoma

Shi Xiang, Wenwen Zhang, Zhichao Wang, Hui Chen, Chao Yang

Translational Cancer Research · 2025-05 · 14 (5) · 2580-2593

DOI: 10.21037/tcr-24-2155 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Cancer Research, 2025-05. Verfasst von Shi Xiang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Oncology Research Center, Jiangxi University of Chinese Medicine, Nanchang, China. Die Arbeit wurde bisher 9-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

HSP90AA1 is a chaperone protein that plays a role in several biological processes, including inflammation and cancer. HSP90AA1 is highly expressed in lung adenocarcinoma (LUAD). However, its exact function is still unclear. This study aimed to identify HSP90AA1 as a potential biomarker for predicting prognosis in LUAD.

Methods

We used bioinformatics methods to analyze the role of HSP90AA1 in LUAD and predict its downstream pathways. Our findings clarified the role of HSP90AA1 in cellular proliferation based on a series of in vitro experiments. Additionally, we investigated its effects on the cell cycle and apoptosis using flow cytometry.

Results

We analyzed the expression levels of HSP90AA1 message RNA (mRNA) and protein in various normal human and tumor tissues using the The Cancer Genome Atlas (TCGA), Clinical Proteomic Tumor Analysis Consortium (CPTAC), and Human Protein Atlas (HPA) databases. Prognostic analysis of selected survival data from the TCGA database indicated that HSP90AA1 expression was associated with clinicopathological stages. The low HSP90AA1 expression group had significantly higher overall survival (OS) and disease-specific survival (DSS) rates than the high expression group. Additionally, the CancerSEA functional similarity analysis showed that HSP90AA1 was involved in several cellular functions. These included cell cycle stimulation, DNA damage response, invasion, and proliferation. Analysis of immune scores and immune cell infiltration using the ESTIMATE and TIMER databases revealed that high HSP90AA1 levels were associated with low infiltration of CD8+ T cells and plasmacytoid dendritic cells (pDCs), while elevated infiltration of Th2 and T helper cells was also noted. Patients with high HSP90AA1 expression had lower scores in patient-derived xenografts, immune scores, and estimated scores. However, they exhibited notably higher T cell rejection rates. In vitro experiments further confirmed that HSP90AA1 knockdown significantly reduced the proliferation of H1299 cells.

Conclusions

These findings show that silencing HSP90AA1 expression or using HSP90AA1 inhibitors effectively improves treatment outcomes for LUAD. Targeting HSP90AA1 could be a powerful treatment strategy for LUAD.

Schlagwörter

Stichwörter der Autor:innen

HSP90AA1biomarkercell cyclelung adenocarcinoma (LUAD)prognosis

Autor:innen und Institutionen

  • Oncology Research Center, Jiangxi University of Chinese Medicine, Nanchang, China.
  • Jiangxi Provincial Key Laboratory of Chinese Medicine Diagnosis and Rehabilitation of Malignant Tumors, Jiangxi University of Chinese Medicine, Nanchang, China.

Zitieren

APA

Xiang, S., Zhang, W., Wang, Z., Chen, H., & Yang, C. (2025). Evaluating HSP90AA1 as a predictive biomarker for prognosis in lung adenocarcinoma. Translational Cancer Research, 14(5), 2580-2593. https://doi.org/10.21037/tcr-24-2155

Vancouver

Xiang S, Zhang W, Wang Z, Chen H, Yang C. Evaluating HSP90AA1 as a predictive biomarker for prognosis in lung adenocarcinoma. Translational Cancer Research. 2025;14(5):2580-2593. doi:10.21037/tcr-24-2155

BibTeX
@article{Xiang2025,
  author = {Xiang, Shi and Zhang, Wenwen and Wang, Zhichao and Chen, Hui and Yang, Chao},
  title = {Evaluating HSP90AA1 as a predictive biomarker for prognosis in lung adenocarcinoma},
  journal = {Translational Cancer Research},
  year = {2025},
  volume = {14},
  number = {5},
  pages = {2580--2593},
  doi = {10.21037/tcr-24-2155}
}
Kostenlos starten →